Institute of Antler Science and Product Technology, Changchun Sci-Tech University, Changchun, China.
College of Traditional Chinese Medicine, Jilin Agricultural University, Changchun, China.
Cell Transplant. 2023 Jan-Dec;32:9636897231219830. doi: 10.1177/09636897231219830.
Extracellular vesicles (EVs) from antler reserve mesenchymal (RM) cells play an important role in the paracrine regulation during rapid growth of antler without forming a tumor; therefore, RM-EVs become novel materials for anti-tumor studies, such as osteosarcoma treatment. However, the problem of low production of RM-EVs in traditional 2D culture limits its mechanism research and application. In this study, we established an optimal 3D culture system for antler RM cells to produce EVs (3D-RM-EVs). Morphology and property of harvested 3D-RM-EVs were normal compared with EVs from conventional 2D culture, and the miRNA profile in them was basically the same through transcriptome sequencing analysis. Based on the same number of RM cells, the volume of the culture medium collected by 3D cultural system concentrated nearly 30 times, making it more convenient for subsequent purification. In addition, EVs were harvested 30 times in 3D cultural system, greatly increasing the total amount of EVs (harvested a total of 2-3 times in 2D culture). Although 3D-RM-EVs had a limited inhibitory effect on the proliferation of K7M2 cells, the inhibition effect of 3D-RM-EVs loaded drugs (Ifosfamide + Etoposide) were more significant than that of positive drug group alone ( < 0.05). Furthermore, studies showed that 3D-RM-EVs loaded drugs (Ifosfamide + Etoposide) had the most significant tumor inhibition effect, with decreased tumor size, and could slow down body weight loss compared with Ifosfamide + Etoposide (IFO + ET) group. These results demonstrated that 3D-RM-EVs were efficiently prepared from antler RM cells and were effective as drug vehicles for the treatment of osteosarcoma.
鹿茸间充质细胞(RM)来源的细胞外囊泡(EVs)在鹿茸快速生长过程中发挥旁分泌调节作用,而不会形成肿瘤;因此,RM-EVs 成为抗骨肿瘤研究的新型材料,如骨肉瘤的治疗。然而,传统 2D 培养中 RM-EVs 产量低的问题限制了其机制研究和应用。本研究建立了鹿茸 RM 细胞产生 EVs(3D-RM-EVs)的最佳 3D 培养体系。与传统 2D 培养的 EVs 相比,收获的 3D-RM-EVs 的形态和特性正常,通过转录组测序分析,其 miRNA 谱基本相同。基于相同数量的 RM 细胞,3D 培养系统收集的培养基体积浓缩了近 30 倍,更便于后续的纯化。此外,在 3D 培养系统中,EVs 可收获 30 次,大大增加了 EVs 的总量(在 2D 培养中总共可收获 2-3 次)。尽管 3D-RM-EVs 对 K7M2 细胞的增殖有一定的抑制作用,但载药(异环磷酰胺+依托泊苷)3D-RM-EVs 的抑制作用比阳性药物组更显著(<0.05)。此外,研究表明,载药(异环磷酰胺+依托泊苷)3D-RM-EVs 具有最显著的肿瘤抑制作用,肿瘤体积减小,与异环磷酰胺+依托泊苷(IFO+ET)组相比,体重下降速度较慢。这些结果表明,3D-RM-EVs 可从鹿茸 RM 细胞中高效制备,并可作为骨肉瘤治疗的有效药物载体。